Skip to main content
Clinical Trials/NCT04320901
NCT04320901UnknownNot Applicable

Comparative Analysis Between Harmonic Versus LigaSure in Transoral Endoscopic Thyroidectomy: A Randomized Controlled Trial

Inha University Hospital1 site in 1 country40 target enrollmentStarted: April 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
40
Locations
1
Primary Endpoint
Blood loss

Study Overview

Brief Summary

Open label randomized controlled study, for Harmonic versus Ligasure in transoral endoscopic thyroid surgery.

Detailed Description

  • This is a prospective randomized controlled study. The principal investigator or another clinical investigator in charge will individually inform the patients about the study, on the day before surgery.
  • When informed consent is obtained, an investigator in charge of randomization only, will randomize the patients.
  • According to randomization, the experimental group will Ligasure and the control group will use Harmonic ACE 7+. Other than the randomized use of energy devices, the protocol for TOETVA is performed as usual.
  • Operation time (from insertion of the laparoscopic camera to removal of the camera), number of times the camera was cleaned, intraoperative blood loss will recorded.
  • Postoperative hospital stay, visual analog pain scale, blood cell count and inflammatory parameters, postoperative drain amount will recorded.
  • Complications of thyroid surgery (vocal cord dysfunction, hypoparathyroidism) are compared for safety assessment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who planned to transoral endoscopic thyroidectomy
  • •Age between 20 to 70
  • •Voluntarily consenting to the study and study agreement
  • •No local invasion or distant metastasis
  • •Normal vocal cord function in laryngoscopic exam
  • •No significant abnormalities in preoperative laboratory tests

Exclusion Criteria

  • •Take aspirin or antiplatelet drugs within 7 days before admission
  • •Uncontrolled hypertension, diabetes, chronic renal failure, or coagulation disease
  • •History of cardiovascular disease (angina pectoris, heart failure, myocardial infarction, history of coronary artery disease, stroke, transient ischemic attack)
  • •Substance abuse and alcohol abuse
  • •History of esophageal and airway diseases
  • •Patient was participated in other clinical trials within 30 days
  • •History of neck irradiation or surgery
  • •History of severe drug allergies
  • •Pregnant or lactating women

Arms & Interventions

Harmonic

Experimental

Endoscopic procedure will be done by Harmonic ACE7+

Intervention: Harmonic (Device)

Ligasure

Experimental

Endoscopic procedure will be done by Ligasure

Intervention: Ligasure (Device)

Outcomes

Primary Outcomes

Blood loss

Time Frame: During the procedure

Estimated blood loss during the lobectomy

Camera cleaning frequency

Time Frame: During the procedure

Numbers of camera cleaning during the lobectomy

Operation time

Time Frame: During the procedure

Surgery time during the thyroid lobectomy

Secondary Outcomes

  • Drain amount(Postoperative 1st and 2nd days)
  • Pain score(Postoperative 1st and 2nd days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jin Wook Yi

Assistant Professor

Inha University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Energy Device Study in Transoral... | Clinical Trial